If you are making a decision about Disease Modifying Drug treatment of your Multiple Sclerosis, this
web site will be of value to you.
This site has been created with funding from the UK Department of Health
as an independent source of assistance and advice. It can help you in two
different ways . . .
Firstly, it will help you to decide
whether or not to embark on a course of treatment with interferon beta,
glatiramer acetate or natalizumab. These are licensed disease modifying drugs (DMDs) which may slow
the progression of your MS
Secondly, if you are considering
treatment with a self-administered DMD (interferon beta or glatiramer acetate), it has a decision
aid to help you to decide, together with your neurologist which of the five drugs currently available
would be best for you, if you do decide to go ahead
This website is for you if:
- You live in the United Kingdom and are eligible for NHS treatment,
and
- You are an adult over 18, and
- You have already been told by your neurology consultant that
you are eligible for treatment with Disease Modifying Drugs, and
- You are currently considering whether to take these drugs and deciding
which drug would be best for you to take
An important long term decision
Now that you have been offered this type of treatment, there are a number
of things for you to think about before you make your decision. This treatment
is usually long term, and should not be embarked on without reviewing all
the issues involved.
This site is not a substitute for medical advice.
Please remember that the information we will provide is only a guide.
However, it will help you to clarify your thinking and prepare for a careful
decision in collaboration with your specialist.
